肠道微生物群、益生菌与人类健康。
Gut microbiota, probiotics, and human health.
机构信息
1 Department of Molecular Microbiology, Institute for Experimental Medicine, Acad. Pavlov Street 12, Saint-Petersburg 197376, Russia.
出版信息
Biosci Microbiota Food Health. 2013;32(3):81-91. doi: 10.12938/bmfh.32.81. Epub 2013 Jul 25.
Abstract
The review is devoted to the problems of microbiota and the ways of it correction employing beneficial life bacteria- probiotics. It covers the issues related to the functioning of human microbiota and its importance for the health, individual variability of microbial content, functioning of the probiotics in the human organism and the history of probiotic studies with particular focus on the microbiological investigations in the USSR. The article discusses the safety issues related to probiotics and the problems with probiotic therapy, trying to explain the reasons for the side effects caused by probiotics. The necessity of personified selection of the probiotic strain or individual microbial therapy autoprobiotics is also discussed.
摘要
这篇综述致力于研究微生物群及其利用有益生活细菌——益生菌进行纠正的问题。它涵盖了与人类微生物群的功能及其对健康的重要性、微生物含量的个体变异性、益生菌在人体中的作用以及益生菌研究的历史有关的问题，特别关注苏联的微生物学研究。本文讨论了与益生菌相关的安全问题和益生菌治疗的问题，试图解释益生菌引起副作用的原因。还讨论了个体化选择益生菌菌株或个体微生物治疗自益生菌的必要性。
相似文献
1
Gut microbiota, probiotics, and human health.肠道微生物群、益生菌与人类健康。
Biosci Microbiota Food Health. 2013;32(3):81-91. doi: 10.12938/bmfh.32.81. Epub 2013 Jul 25.
2
Gut enterotypes are stable during Bifidobacterium and Lactobacillus probiotic supplementation.肠道菌型在补充双歧杆菌和乳杆菌益生菌时是稳定的。
J Food Sci. 2020 May;85(5):1596-1604. doi: 10.1111/1750-3841.15127. Epub 2020 Apr 8.
3
Changes in the Functional Potential of the Gut Microbiome Following Probiotic Supplementation during Helicobacter Pylori Treatment.幽门螺杆菌治疗期间补充益生菌后肠道微生物群功能潜力的变化。
Helicobacter. 2016 Dec;21(6):493-503. doi: 10.1111/hel.12306. Epub 2016 Mar 18.
4
Effects of Lactococcus lactis subsp. lactis JCM5805 on colonization dynamics of gut microbiota and regulation of immunity in early ontogenetic stages of tilapia.乳球菌乳亚种 JCM5805 对罗非鱼早期发育阶段肠道微生物群落定植动态和免疫调节的影响。
Fish Shellfish Immunol. 2019 Mar;86:53-63. doi: 10.1016/j.fsi.2018.11.022. Epub 2018 Nov 11.
5
Gut Microbiota Alteration After Long-Term Consumption of Probiotics in the Elderly.老年人长期食用益生菌后肠道微生物群的改变。
Probiotics Antimicrob Proteins. 2019 Jun;11(2):655-666. doi: 10.1007/s12602-018-9403-1.
6
Beneficial microbiota. Probiotics and pharmaceutical products in functional nutrition and medicine.有益菌群。功能性营养和医学中的益生菌和医药产品。
Microbes Infect. 2020 Jan-Feb;22(1):8-18. doi: 10.1016/j.micinf.2019.06.004. Epub 2019 Jun 21.
7
Tackling probiotic and gut microbiota functionality through proteomics.通过蛋白质组学研究益生菌和肠道微生物群的功能
J Proteomics. 2016 Sep 16;147:28-39. doi: 10.1016/j.jprot.2016.03.023. Epub 2016 Mar 18.
8
Probiotic-enriched milk and dairy products increase gut microbiota diversity: a comparative study.富含益生菌的牛奶和乳制品可增加肠道微生物多样性：一项比较研究。
Nutr Res. 2020 Oct;82:25-33. doi: 10.1016/j.nutres.2020.06.017. Epub 2020 Jul 6.
9
[Probiotics intake as gut-microbiota modulating therapy in an interdisciplinary aspect].[从跨学科角度看，摄入益生菌作为肠道微生物群调节疗法]
Pol Merkur Lekarski. 2020 Aug 22;49(286):279-281.
10
Oral Administration of Compound Probiotics Improved Canine Feed Intake, Weight Gain, Immunity and Intestinal Microbiota.口服复合益生菌可改善犬只采食量、体重增加、免疫力和肠道微生物群。
Front Immunol. 2019 Apr 2;10:666. doi: 10.3389/fimmu.2019.00666. eCollection 2019.
引用本文的文献
1
Gut Microbiome Interventions: From Dysbiosis to Next-Generation Probiotics (NGPs) for Disease Management.肠道微生物群干预：从生态失调到用于疾病管理的下一代益生菌（NGPs）
Probiotics Antimicrob Proteins. 2025 May 28. doi: 10.1007/s12602-025-10582-7.
2
Autoprobiotics in the Treatment of Patients with Colorectal Cancer in the Early Postoperative Period.自体益生菌在结直肠癌患者术后早期的治疗应用
Microorganisms. 2024 May 13;12(5):980. doi: 10.3390/microorganisms12050980.
3
provides protection during scavenging in carrion crow ( ).在食腐中为寒鸦提供保护（ ）。
Zool Res. 2024 May 18;45(3):451-463. doi: 10.24272/j.issn.2095-8137.2023.320.
4
Prebiotic effect of galacto--biose on the intestinal lactic acid bacteria as enhancer of acetate production and hypothetical colonization.半乳糖-二糖对肠道乳杆菌的益生元作用，作为乙酸产生和假设定植的增强剂。
Appl Environ Microbiol. 2024 Mar 20;90(3):e0144523. doi: 10.1128/aem.01445-23. Epub 2024 Feb 27.
5
Probiotics and autoprobiotics for treatment of infection.用于治疗感染的益生菌和自身益生菌。
World J Clin Cases. 2023 Jul 16;11(20):4740-4751. doi: 10.12998/wjcc.v11.i20.4740.
6
Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study.共生元在接受自体造血干细胞移植患者中的疗效和安全性：一项随机、双盲、安慰剂对照的初步研究。
Intern Med. 2023 Oct 15;62(20):2949-2958. doi: 10.2169/internalmedicine.1314-22. Epub 2023 Feb 15.
7
Secondary Dysfunction of the Intestinal Barrier in the Pathogenesis of Complications of Acute Poisoning.急性中毒并发症发病机制中肠屏障的继发性功能障碍
J Evol Biochem Physiol. 2022;58(4):1075-1098. doi: 10.1134/S0022093022040123. Epub 2022 Aug 28.
8
Effects of HY7601 and KY1032 on Overweight and the Gut Microbiota in Humans: Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.HY7601 和 KY1032 对超重人群及肠道微生物群的影响：一项随机、双盲、安慰剂对照的临床试验。
Nutrients. 2022 Jun 15;14(12):2484. doi: 10.3390/nu14122484.
9
The role of microbiota in colorectal cancer.肠道微生物群在结直肠癌中的作用。
Folia Microbiol (Praha). 2022 Oct;67(5):683-691. doi: 10.1007/s12223-022-00978-1. Epub 2022 May 10.
10
Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper.特定生物标志物模式所反映的全身效应有助于前列腺癌管理的范式转变：一篇战略论文。
Cancers (Basel). 2022 Jan 28;14(3):675. doi: 10.3390/cancers14030675.
本文引用的文献
1
The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?肠道微生物组与炎症性肠病：粪便微生物群移植是否具有治疗作用？
Am J Gastroenterol. 2012 Oct;107(10):1452-9. doi: 10.1038/ajg.2012.93.
2
Safety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: results from a randomized masked trial.鼠李糖乳杆菌 DSM 17938 的安全性和耐受性及其对健康成年人生物标志物的影响：一项随机、双盲试验的结果。
PLoS One. 2012;7(9):e43910. doi: 10.1371/journal.pone.0043910. Epub 2012 Sep 6.
3
New insights in gut microbiota establishment in healthy breast fed neonates.健康母乳喂养新生儿肠道微生物群建立的新见解。
PLoS One. 2012;7(8):e44595. doi: 10.1371/journal.pone.0044595. Epub 2012 Aug 30.
4
Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows.乳酸菌对肠道微生物多样性的贡献：利与弊。
Front Cell Infect Microbiol. 2012 Jun 22;2:86. doi: 10.3389/fcimb.2012.00086. eCollection 2012.
5
Gut microbiota and developmental programming of the brain: from evidence in behavioral endophenotypes to novel perspective in obesity.肠道微生物群与大脑的发育编程：从行为内表型的证据到肥胖的新视角。
Front Cell Infect Microbiol. 2012 Aug 15;2:109. doi: 10.3389/fcimb.2012.00109. eCollection 2012.
6
Probiotics, symptoms, and gut microbiota: what are the relations? A randomized controlled trial in subjects with irritable bowel syndrome.益生菌、症状和肠道微生物群：它们之间有什么关系？一项针对肠易激综合征患者的随机对照试验。
Gastroenterol Res Pract. 2012;2012:214102. doi: 10.1155/2012/214102. Epub 2012 Jul 31.
7
Fibrinogen-binding and platelet-aggregation activities of a Lactobacillus salivarius septicaemia isolate are mediated by a novel fibrinogen-binding protein.唾液乳杆菌败血症分离株的纤维蛋白原结合和血小板聚集活性由一种新型纤维蛋白原结合蛋白介导。
Mol Microbiol. 2012 Sep;85(5):862-77. doi: 10.1111/j.1365-2958.2012.08148.x. Epub 2012 Jul 11.
8
Metabolic diseases and pro- and prebiotics: Mechanistic insights.代谢性疾病与益生菌和益生元：作用机制的研究进展。
Nutr Metab (Lond). 2012 Jun 19;9(1):60. doi: 10.1186/1743-7075-9-60.
9
Gut microbiota and nonalcoholic fatty liver disease.肠道微生物群与非酒精性脂肪性肝病。
Ann Hepatol. 2012 Jul-Aug;11(4):440-9.
10
Fecal transplantation for the treatment of Clostridium difficile infection.粪便移植治疗艰难梭菌感染
Gastroenterol Hepatol (N Y). 2012 Mar;8(3):191-4.
Zotero 插件